Federal contractor · public award history
IDORSIA PHARMACEUTICALS US INC
Parent: IDORSIA PHARMACEUTICALS US INC YWKKJS5RYQJ9
- Awards we know about
- 3
- Typical size
- —
- Middle of their public awards
- Dollars on those awards
- $0
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Feb 11, 2027
- Activation date
- Feb 11, 2026
- Primary NAICS (SAM)
- 325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Veterans Affairs (3)
Industries & product codes
Award history
- Department of Veterans Affairs—
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—
2 NDCS FOR OREXIN INHIBITORS. AWARDED FOR A BASE YEAR OF 5/28/2023 TO 5/27/2024 AND 4 ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—
BPA FOR TRYVIO
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.